GGTase-II beta Antibody (B-8)
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0455020-V3
- Awardee
- Santa Cruz Biorechnology, Inc.
- Contracting organization
- University of Virginia
- Cumulative value
- $312.34
About this award
The University of Virginia awarded contract A207_PO-0455020-V3 to Santa Cruz Biotechnology, Inc. on September 26, 2026, with a cumulative contract value of $312. The prime contractor will deliver GGTase-II beta Antibody (B-8) reagents to support the University's research and laboratory operations. This contract encompasses the procurement of 312 units of the specified antibody product at a unit price of $1 per unit.
Santa Cruz Biotechnology, Inc. serves as the sole prime contractor for this Virginia-based procurement. The line item specifies delivery of the GGTase-II beta Antibody (B-8) to the University of Virginia, which functions as both the contracting organization and the delivery destination. No additional contract performance period, annual value, or geographic performance location details beyond the Virginia location are specified in the available award documentation.
Line items
| Item | Total |
|---|---|
| GGTase-II beta Antibody (B-8) | $312.00 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0455020-V3?
Contract A207_PO-0455020-V3 was awarded to Santa Cruz Biorechnology, Inc. by University of Virginia on September 26, 2026.
How much is contract A207_PO-0455020-V3 worth?
Its cumulative value is $312.34.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award